Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
This study is currently recruiting participants.
Verified August 2012
by University of Miami
Study NCT01491022 Information provided by University of Miami
First Received on December 8, 2011. Last Updated on August 29, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Parkinson's Disease
Gait Disorders
Additional conditions recognized in this trial
Parkinson Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders
Interventions listed in this trial
Dalfampridine
placebo
Additional drug interventions recognized in this trial
4-Aminopyridine
More general drug interventions related to this trial
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Potassium Channel Blockers
Therapeutic Uses
Sponsors listed in this trial
University of Miami
Acorda Therapeutics
Back to top of Main Content